Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
about
A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivityAdeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD miceImmunotherapy of type 1 diabetes: lessons for other autoimmune diseases.c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms.Monoclonal antibody-induced cytokine-release syndrome.Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 familyCD28-specific immunomodulating antibodies: what can be learned from experimental models?Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer.DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice.Tolerogenic strategies to halt or prevent type 1 diabetes.A role for CD45RBlow CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes
P2860
Q33753900-99C045F3-D2ED-450C-A1C3-53AF2CE590E5Q33950195-4B974FB9-D1C4-4F9E-83FD-8030F999883AQ33955180-65B30818-4A12-427C-BF0F-7C045E1CB995Q34731064-78BFC88A-F387-4877-9252-808DEDCE2B5BQ36401230-94C91457-A954-4FEF-A5D4-D9F1A5DAF637Q37755276-E3C9091D-58D5-4376-A161-5E39D8B62E50Q37864700-3F7F176D-FE6E-4B16-B392-42CC25AFBFFCQ37999397-09C44B9C-8801-40A2-BC61-4A36164DF264Q43407813-775E7B99-969D-4F0C-A6BD-D3AE6F6F3056Q45873002-DB275D51-5EBE-4B71-B240-00992F9E0E76Q45886074-B51AAD9F-C236-4076-9FB8-8E9312D31284Q48560546-558D4A2C-3415-4A38-9A45-D78306F72D3FQ56907103-511F9B9D-B3DA-42CB-9280-4FF27FC07BE1
P2860
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Neonatal activation of CD28 si ...... y an IL-4-dependent mechanism.
@en
Neonatal activation of CD28 si ...... y an IL-4-dependent mechanism.
@nl
type
label
Neonatal activation of CD28 si ...... y an IL-4-dependent mechanism.
@en
Neonatal activation of CD28 si ...... y an IL-4-dependent mechanism.
@nl
prefLabel
Neonatal activation of CD28 si ...... y an IL-4-dependent mechanism.
@en
Neonatal activation of CD28 si ...... y an IL-4-dependent mechanism.
@nl
P2093
P2860
P356
P1476
Neonatal activation of CD28 si ...... by an IL-4-dependent mechanism
@en
P2093
A Jaramillo
G A Arreaza
K B Laupland
M J Cameron
M J Rapoport
S W Chensue
P2860
P304
P356
10.1172/JCI119762
P407
P577
1997-11-01T00:00:00Z